Study Design Setting Study period Exclusions Cases Controls Test & cut-off Outcomes Dungan (1994) [47 ] Prospective cohort (matched) Tennessee, USA (regional medical centre screening database) Jan 1990 to Dec 1991 Multiples, y False-pos DS screen Screen Neg (matched by age, race, parity, and bleeding) Triple marker (15-20 wk GA) ≥1 : 270 at midgest IUFD, , PET, major anomalies Pergament (1995) [25 ] Retrospective cohort (matched) Illinois, USA (large teaching hospital) Jul 1990 to Jun 1991 Multiples, y False-pos DS screen Screen Neg (matched by age, race, sample date, DM) Triple marker (15-20 wk GA) ≥1 : 250 at midgest PTB, PPROM, abruption, PET, , IUFD, APOs Milunsky (1996) [48 ] Retrospective cohort (matched) Massachusetts, USA (university teaching hospital) 1992 to 1994 Multiples, DM Abn lytes plus screen Pos for DS Normal lytes plus screen Neg for DS (matched by age, GA, and race) Abnormal analyte levels +/- triple marker (15-24 wk GA) ≥1 : 270 at midgest LBW, IUFD, NND, anomalies, DS Chapman (1997) [43 ] Retrospective cohort Alabama, USA (genetic database at university teaching hospital) Aug 1988 to Feb 1995 y, anomalies, abn amnioFalse-pos DS screen plus normal amnio Screen Neg plus normal amnio Double marker (15-20 wk GA) ≥1 : 190 at midgest IUFD, PTB, Hsieh (1997) [44 ] Retrospective cohort adjusted analysis Taipei, Taiwan (university hospital) Jan 1994 to Feb 1996 yFalse-pos DS screen Screen Neg Double marker (14-22 wk GA) ≥1 : 270 at midgest PTB, postdates, , LGA, macrosomia, PET, PPH, PROM, abruption, anomalies, poly, oligo, IUFD Ogle (2000) [45 ] Retrospective cohort (matched) London, UK (university teaching hospital) 22 mo period Multiples, preg dating not done by us False-pos DS screen Screen Neg (matched by age and GA of testing) Double marker (15-18 wk GA) ≥1 : 250 at term IUFD, PTB, PET, IUGR, APOs Spencer (2000) [49 ] Retrospective cohort UK (tertiary hospital prenatal screening program) 1995 to 1998 Multiples, anomalies, abn amnio, preg wk GA outcome outcome Triple marker (15-19 wk GA) >1 : 251 at midgest PTB, SGA, IUGR, IUFD Antsaklis (2001) [50 ] Retrospective cohort (matched) Athens, Greece (large teaching hospital) Jan 1991 to Dec 1998 Multiples, y False-pos DS screen Screen Neg (matched by age & GA at testing) Triple marker (16-20 wk GA) ≥1 : 250 at midgest Fetal death (total and by etiology) Naylor (2001) [51 ] Prospective cohort (matched) California, USA (university teaching hospital) Aug 1995 (start) Non-Hispanics, multiples, HTN, DM, PMHx, anomalies False-pos DS screen plus normal amnio Screen Neg, matched Triple marker (15-20 wk GA) ≥1 : 190 at midgest PET, PTB, , IUFD, APOs Summers (2003) [52 ] Retrospective cohort (matched) Canada (provincial genetic database) Oct 1995 to Sep 1998 Multiples, DM, +NTD screens, anomalies False-pos DS screen Screen Neg (matched by age, ethnicity, test site, sample date) Triple marker (15-20 wk GA) ≥1 : 385 at term PIH, PET, APH, PROM, SGA, PTB, oligo, poly, IUFD, APOs Sritippayawan (2005) [26 ] Retrospective cohort (matched) Bangkok, Thailand (university teaching hospital) Mar 1998 to Aug 2002 Multiples, DM, anomalies, aneuploidy, missing info, POBHx or FamHx, +NTD or unknown screen False-pos DS screen Screen Neg (matched by age, parity, and date of testing) Double marker (14-21 wk GA) ≥1 : 270 at midgest PTB, LBW, SGA, PET, previa, IUFD, APOs Xia (2006) [53 ] Retrospective cohort Shanghai, China (university teaching hospital) Apr 2002 to Mar 2005 Multiples False-pos DS screen Screen Neg Triple marker (13-21 wk GA) ≥1 : 384 at term IUGR, BGI, NBI, OSB, IUFD, distress, APOs Weintraub (2012) [54 ] Retrospective cohort Negev, Israel (university teaching hospital) ᴓ Abnormal levels of individual analytes False-pos DS screen (normal lytes & amnio) Screen Neg Triple marker (15-20 wk GA) ≥1 : 380 at term Abn lytes, amnio, GDM, poly, IUGR, PROM, PTB, postdates, IOL, augmentation, breech, FTP, distress, mec, mode, GA, BWt, gender, Apgars, LGA, AGA, SGA, cardiac anomalies, PPH Rodrigues (2013) [46 ] Retrospective cohort (matched) Lisbon, Portugal (hospital database) Mar 2003 to Aug 2007 Multiples False-pos T1 or T2 double marker screen Screen Neg (matched by age, GA at testing, and type of screen) PN screening cohort of 4422 (T1 integrated or T1 serum integrated or T2 double marker) vs controls PTB, IUGR, HDP Godbole (2015) Retrospective cohort Pune, India (tertiary care private hospital) 2 years Abnormal chx “High risk” screen “Low risk” screen Triple marker ( ) vs T1 double marker ( ) PTB, LBW, oligo, CS, PIH, NICU admission, resp distress Yazdani (2015) [55 ] Retrospective cohort Babol, Iran (university teaching hospital) Mar 2012 to 2013 Chronic HTN, DM, renal dis, heart dis, thal, thyroid dis, multiples, family hx, pos amnio False-pos DS screen Screen Neg Quad marker (14-18 wk GA) Composite APO, anemia, mode of del, infertility, UTI, GDM, GHTN, PET, PTL, IUGR, poly, oligo, PROM, skin dis, abruption